About Koye Pharmaceuticals Private Limited
Data last updated:
Koye Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Koye Enterprises Llp. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2013PTC243214. Its GSTIN is 27AAFCK2001H1Z0 (Maharashtra). The company holds 20 GST registrations, of which 18 are active.
The company has an authorised share capital of ₹46.01 Cr and a paid-up capital of ₹21.58 Cr. It is led by directors including Ravindra Yogesh Shenoy and Preetish Mohan Toraskar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sf A – 01 Art Guild House Phoenix Market City Annexe, Lbs Marg Kurla (West) Mumbai, Maharashtra, India – 400070.
As per the financials filed for FY 2025, the company reported a revenue of ₹129.09 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net loss of ₹12.28 Cr (net margin -9.5%) and EBITDA of ₹29.43 Cr (EBITDA margin 22.8%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 13% over five years.
The company has about 673 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Koye. As per MCA filings, the company has open charges of ₹101.45 Cr and satisfied charges of ₹149.76 Cr on record. Court records list 24 cases involving the company, including 13 filed by the company and 11 filed against it; 13 cases are pending. The company has 16 deals on record (7 funding rounds, 7 debt financings, 1 secondary share transfer), with disclosed funding of ₹407.53 Cr; the latest was in December 2025. Its 7 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Prosperity Drugs Private Limited with revenue of ₹131.43 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website koye.co.
Company details
Contact details
Koye Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is koye.co. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSf A – 01 Art Guild House Phoenix Market City Annexe, Lbs Marg Kurla (West) Mumbai, Maharashtra, India – 400070
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Koye Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Koye Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Koye Pharmaceuticals Private Limited, buy the company report.
Financials of Koye Pharmaceuticals Private Limited
FY 2024 filings availableKoye Pharmaceuticals Private Limited reported revenue of ₹129.09 Cr (down 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 4% fall in the latest year. EBITDA rose 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.43 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹12.28 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.8% | ||||
| Net Profit Margin | -9.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Koye Pharmaceuticals Private Limited, buy the company report.
Board of directors of Koye Pharmaceuticals Private Limited
Koye Pharmaceuticals has 3 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravindra Yogesh Shenoy | Director | 16 Jul 2013 | 13 Years 3 Months | Current |
| Preetish Mohan Toraskar Also directs: Koye Enterprises LLP, Blue Oyster Enterprises LLP, Koye Endeavours Private Limited and 3 more | Director | 09 Sep 2013 | 13 Years 1 Months | Current |
| Vishal Kaushik | Director | 27 Aug 2025 | 1 Years 2 Months | Current |
Peer comparison
Koye Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prosperity Drugs Private Limited | ₹131.43 Cr (FY 2025) | -1.0% | Solan, Himachal Pradesh, India | |||
| Dey's Medical Stores (Manufacturing) Ltd | ₹130.35 Cr (FY 2025) | -2.0% | Kolkata, West Bengal, India | |||
| Elder Prroject Limited | ₹129.37 Cr (FY 2022) | 18.0% | Mumbai, Maharashtra, India | |||
| Maxim Pharmaceuticals Private Limited | ₹129.31 Cr (FY 2025) | -6.0% | Pune, Maharashtra, India | |||
| Koye Pharmaceuticals Private Limitedthis company | ₹129.09 Cr (FY 2025) | -₹12.28 Cr | -9.5% | -4.0% | 673 | Mumbai, Maharashtra, India |
| Centurion Remedies Private Limited | ₹128.35 Cr (FY 2025) | -10.0% | Vadodara, Gujarat, India | |||
| Encore Healthcare Private Limited | ₹128.04 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Super Formulations Private Limited | ₹123.88 Cr (FY 2024) | 17.0% | Ujjain, Madhya Pradesh, India |
To see the full peer comparison of Koye Pharmaceuticals Private Limited, buy the company report.
Auditor
Koye Pharmaceuticals Private Limited is audited by DELOITTE HASKINS & SELLS LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DELOITTE HASKINS & SELLS LLP | FY 2023 | 117366W/ W-100018 |
Shareholding
The shareholding of Koye Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Koye Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Feb 2023 | 100686150 | Others | ₹20 Cr | Open | |
| 22 Mar 2022 | 100572127 | Others | ₹36.85 Cr | Open | |
| 14 Jan 2022 | 100549965 | Tjsb Sahakari Bank Limited | ₹3 Cr | Open | |
| 26 Oct 2021 | 100513110 | Axis Bank Limited | ₹15 Cr | Open | |
| 18 May 2021 | 100454009 | Axis Bank Limited | ₹26.6 Cr | Open |
To see the full charge records of Koye Pharmaceuticals Private Limited, buy the company report.
Total charge records: 20 View all charges
Deals & funding
Koye Pharmaceuticals Private Limited has 16 deals on record (7 funding rounds, 7 debt financings, 1 secondary share transfer), with disclosed funding of ₹407.53 Cr; the latest was in December 2025.
Deals on record (5 of 16)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2025 | Funding round | ₹3.33 Cr | Investors: Aries Health Limited |
| Jul 2025 | Funding round | ₹9.3 Cr | Investors: Aries Health Limited |
| Sep 2021 | Debt financing | ₹9.8 Cr | Investors: Blacksoil Group |
| Jul 2020 | Debt financing | ₹5.5 Cr | Investors: Blacksoil Group |
| Jul 2013 | Acquisition | ₹41.24 Cr | Buyer: Koye Enterprises LLP Seller: 2 individuals |
To see the full deal history of Koye Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Koye Pharmaceuticals Private Limited has 24 court cases on record: 13 filed by Koye Pharmaceuticals, 11 filed against it. 13 cases are pending and 11 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 13 | 0 | 7 |
| District courts | 9 | 9 | 6 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (5 of 24)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Commercial matter | Filed against the company by Spray Engineering Devices Limited Through Its Authorized Representative Rinkal Goyal | Pending |
| District court, Kargil, Ladakh | Court case (Complaint) | Filed against the company | Pending |
| District court, Pathankot, Punjab | Commercial suit | Filed against the company | Pending |
| District court, Haridwar, Uttarakhand | Criminal case | Filed against the company by M/S Francis Remedies Pvt. Ltd. | Pending |
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed against the company by M/S. MSP Lab Instruments | Pending |
To see the full case history of Koye Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Koye Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Koye Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Koye Foundation | U85300MH2019NPL332414 |
To see the full group structure of Koye Pharmaceuticals Private Limited, buy the company report.
Employees & EPFO
Koye Pharmaceuticals Private Limited has a workforce of 673 employees on its EPFO records as of Jan 23, 2025, across 1 active EPFO establishment.
GST
Koye Pharmaceuticals has 20 GST registrations: 18 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCK2001H1Z0 | Maharashtra | Active | 01 Jul 2017 |
| 27AAFCK2001H3ZY | Maharashtra | Active | 08 Dec 2021 |
| 09AAFCK2001H1ZY | Uttar Pradesh | Active | 01 Jul 2017 |
| 33AAFCK2001H1Z7 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Koye Pharmaceuticals Private Limited, buy the company report.
Recent activity
Koye Pharmaceuticals Private Limited has 15 board changes on record since 2013: 3 appointments and 12 cessations. The latest: Vishal Kaushik ceased to be Additional Director on 22 Dec 2025.
46 earlier events are in the company report.
Frequently asked questions
Koye Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 May 2013 (13+ years old) and is registered under CIN U74120MH2013PTC243214.
Koye Pharmaceuticals has 3 current directors:
- Ravindra Yogesh Shenoy - Director
- Preetish Mohan Toraskar - Director
- Vishal Kaushik - Director
The latest financial statements of Koye Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Koye Pharmaceuticals is 27AAFCK2001H1Z0, registered in Maharashtra. The company has 20 GST registrations in all, of which 18 are active and 2 are cancelled or inactive. Other active GSTINs include 27AAFCK2001H3ZY (Maharashtra), 09AAFCK2001H1ZY (Uttar Pradesh), 33AAFCK2001H1Z7 (Tamil Nadu).
The CIN (Corporate Identification Number) of Koye Pharmaceuticals is U74120MH2013PTC243214. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Koye Pharmaceuticals has 24 court cases on record: 13 filed by the company and 11 filed against it. 13 are pending. Most are in the high courts.
Koye Pharmaceuticals was incorporated on 12 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Koye Pharmaceuticals has 16 deals on record (7 funding rounds, 7 debt financings, 1 secondary share transfer), with disclosed funding of ₹407.53 Cr; the latest was in December 2025.
The peers of Koye Pharmaceuticals by revenue are Prosperity Drugs Private Limited, Dey's Medical Stores (Manufacturing) Ltd, Elder Prroject Limited, Maxim Pharmaceuticals Private Limited, Centurion Remedies Private Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vishal Kaushik ceased to be Additional Director on 22 Dec 2025. Vishal Kaushik was appointed as Director on 27 Aug 2025. Bharat Singh ceased to be Nominee Director on 30 Sep 2024. Koye Pharmaceuticals has 15 board changes on record in total.
Koye Pharmaceuticals can be reached through the website koye.co. Its registered office is in Mumbai, Maharashtra, India.